187 related articles for article (PubMed ID: 36760747)
1. Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores.
Whitehouse RL; Alwan WS; Ilyichova OV; Taylor AJ; Chandrashekaran IR; Mohanty B; Doak BC; Scanlon MJ
RSC Med Chem; 2023 Jan; 14(1):135-143. PubMed ID: 36760747
[TBL] [Abstract][Full Text] [Related]
2. Hot spot analysis for driving the development of hits into leads in fragment-based drug discovery.
Hall DR; Ngan CH; Zerbe BS; Kozakov D; Vajda S
J Chem Inf Model; 2012 Jan; 52(1):199-209. PubMed ID: 22145575
[TBL] [Abstract][Full Text] [Related]
3. Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites.
Khan O; Jones G; Lazou M; Joseph-McCarthy D; Kozakov D; Beglov D; Vajda S
J Chem Inf Model; 2024 Mar; 64(6):2084-2100. PubMed ID: 38456842
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.
Draxler SW; Bauer M; Eickmeier C; Nadal S; Nar H; Rangel Rojas D; Seeliger D; Zeeb M; Fiegen D
J Med Chem; 2020 Jun; 63(11):5856-5864. PubMed ID: 32420743
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping.
Thomas SE; Collins P; James RH; Mendes V; Charoensutthivarakul S; Radoux C; Abell C; Coyne AG; Floto RA; von Delft F; Blundell TL
Philos Trans A Math Phys Eng Sci; 2019 Jun; 377(2147):20180422. PubMed ID: 31030650
[TBL] [Abstract][Full Text] [Related]
6. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
Silvestre HL; Blundell TL; Abell C; Ciulli A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12984-9. PubMed ID: 23872845
[TBL] [Abstract][Full Text] [Related]
7. A fragment based competitive 19F LB-NMR platform for hotspot directed ligand profiling.
McCarthy WJ; Thomas SE; Olaleye T; Boland JA; Floto RA; Williams G; Blundell TL; Coyne AG; Abell C
Angew Chem Int Ed Engl; 2024 Jun; ():e202406846. PubMed ID: 38896426
[TBL] [Abstract][Full Text] [Related]
8. Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores.
Barillari C; Marcou G; Rognan D
J Chem Inf Model; 2008 Jul; 48(7):1396-410. PubMed ID: 18570371
[TBL] [Abstract][Full Text] [Related]
9. Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.
Mok NY; Maxe S; Brenk R
J Chem Inf Model; 2013 Mar; 53(3):534-44. PubMed ID: 23451880
[TBL] [Abstract][Full Text] [Related]
10. Rapid Elaboration of Fragments into Leads by X-ray Crystallographic Screening of Parallel Chemical Libraries (REFiL
Bentley MR; Ilyichova OV; Wang G; Williams ML; Sharma G; Alwan WS; Whitehouse RL; Mohanty B; Scammells PJ; Heras B; Martin JL; Totsika M; Capuano B; Doak BC; Scanlon MJ
J Med Chem; 2020 Jul; 63(13):6863-6875. PubMed ID: 32529824
[TBL] [Abstract][Full Text] [Related]
11. Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.
Landon MR; Lieberman RL; Hoang QQ; Ju S; Caaveiro JM; Orwig SD; Kozakov D; Brenke R; Chuang GY; Beglov D; Vajda S; Petsko GA; Ringe D
J Comput Aided Mol Des; 2009 Aug; 23(8):491-500. PubMed ID: 19521672
[TBL] [Abstract][Full Text] [Related]
12. Identification and optimization of PDE10A inhibitors using fragment-based screening by nanocalorimetry and X-ray crystallography.
Recht MI; Sridhar V; Badger J; Bounaud PY; Logan C; Chie-Leon B; Nienaber V; Torres FE
J Biomol Screen; 2014 Apr; 19(4):497-507. PubMed ID: 24375910
[TBL] [Abstract][Full Text] [Related]
13. Robust identification of binding hot spots using continuum electrostatics: application to hen egg-white lysozyme.
Hall DH; Grove LE; Yueh C; Ngan CH; Kozakov D; Vajda S
J Am Chem Soc; 2011 Dec; 133(51):20668-71. PubMed ID: 22092261
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibitors and drugs from fragment and virtual screening.
Roughley S; Wright L; Brough P; Massey A; Hubbard RE
Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
[TBL] [Abstract][Full Text] [Related]
15. High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits.
Schiebel J; Krimmer SG; Röwer K; Knörlein A; Wang X; Park AY; Stieler M; Ehrmann FR; Fu K; Radeva N; Krug M; Huschmann FU; Glöckner S; Weiss MS; Mueller U; Klebe G; Heine A
Structure; 2016 Aug; 24(8):1398-1409. PubMed ID: 27452405
[TBL] [Abstract][Full Text] [Related]
16. Exploring protein hotspots by optimized fragment pharmacophores.
Bajusz D; Wade WS; Satała G; Bojarski AJ; Ilaš J; Ebner J; Grebien F; Papp H; Jakab F; Douangamath A; Fearon D; von Delft F; Schuller M; Ahel I; Wakefield A; Vajda S; Gerencsér J; Pallai P; Keserű GM
Nat Commun; 2021 May; 12(1):3201. PubMed ID: 34045440
[TBL] [Abstract][Full Text] [Related]
17. Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1α protein-protein interface.
Van Molle I; Thomann A; Buckley DL; So EC; Lang S; Crews CM; Ciulli A
Chem Biol; 2012 Oct; 19(10):1300-12. PubMed ID: 23102223
[TBL] [Abstract][Full Text] [Related]
18. Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.
Vester K; Metz A; Huber S; Loll B; Wahl MC
Acta Crystallogr D Struct Biol; 2023 Apr; 79(Pt 4):304-317. PubMed ID: 36974964
[TBL] [Abstract][Full Text] [Related]
19. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).
Zhong M; Lynch A; Muellers SN; Jehle S; Luo L; Hall DR; Iwase R; Carolan JP; Egbert M; Wakefield A; Streu K; Harvey CM; Ortet PC; Kozakov D; Vajda S; Allen KN; Whitty A
Biochemistry; 2020 Feb; 59(4):563-581. PubMed ID: 31851823
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.
O'Reilly M; Cleasby A; Davies TG; Hall RJ; Ludlow RF; Murray CW; Tisi D; Jhoti H
Drug Discov Today; 2019 May; 24(5):1081-1086. PubMed ID: 30878562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
